Abstract
Background: Buprenorphine is quite common in the illicit market. Buprenorphinecontaining drug abuse is frequently encountered in patients. The analysis methods used to determine the abuse of buprenorphine and norbuprenorphine are important for forensic science. Buprenorphine is metabolized to norbuprenorphine by the liver.
Objective: Therefore, the determination of buprenorphine and norbuprenorphine in urine is one of the methods to determine the abuse of buprenorphine.
Methods: In this study, we developed a precise, simple, and rapid ultra-performance liquid chromatography- tandem mass spectrometer method for the determination of buprenorphine and norbuprenorphine simultaneously.
Results: The developed method was validated in terms of selectivity and linearity, which was in the range of 9–1800 ng/mL for both buprenorphine and norbuprenorphine. The intra-assay and inter-assay accuracy and precision were found within acceptable limits of the EMA guideline. Lower limits of quantitation were 9 ng/mL for both buprenorphine and norbuprenorphine.
Conclusion: The developed method was successfully applied for the determination of both analytes in the proficiency testing samples.
Keywords: Buprenorphine, norbuprenorphine, proficiency testing, method validation, UPLC-MS/MS, urine samples.
Graphical Abstract
[1]
Morgan, J.R.; Schackman, B.R.; Leff, J.A.; Linas, B.P.; Walley, A.Y. Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured population. J. Subst. Abuse Treat., 2018, 85, 90-96.
[http://dx.doi.org/10.1016/j.jsat.2017.07.001] [PMID: 28733097]
[http://dx.doi.org/10.1016/j.jsat.2017.07.001] [PMID: 28733097]
[2]
Turner, L.; Kruszewski, S.P.; Alexander, G.C. Trends in the use of buprenorphine by office-based physicians in the United States, 2003-2013. Am. J. Addict., 2015, 24(1), 24-29.
[http://dx.doi.org/10.1111/ajad.12174] [PMID: 25823632]
[http://dx.doi.org/10.1111/ajad.12174] [PMID: 25823632]
[3]
Cicero, T.J.; Ellis, M.S.; Chilcoat, H.D. Understanding the use of diverted buprenorphine. Drug Alcohol Depend., 2018, 193, 117-123.
[http://dx.doi.org/10.1016/j.drugalcdep.2018.09.007] [PMID: 30359928]
[http://dx.doi.org/10.1016/j.drugalcdep.2018.09.007] [PMID: 30359928]
[4]
Chilcoat, H.D.; Amick, H.R.; Sherwood, M.R.; Dunn, K.E. Buprenorphine in the United States: Motives for abuse, misuse, and diversion. J. Subst. Abuse Treat., 2019, 104, 148-157.
[http://dx.doi.org/10.1016/j.jsat.2019.07.005] [PMID: 31370979]
[http://dx.doi.org/10.1016/j.jsat.2019.07.005] [PMID: 31370979]
[5]
Chiang, C.N.; Hawks, R.L. Pharmacokinetics of the combination tablet of buprenorphine and naloxone. Drug Alcohol Depend., 2003, 70(2)(Suppl.), S39-S47.
[http://dx.doi.org/10.1016/S0376-8716(03)00058-9] [PMID: 12738349]
[http://dx.doi.org/10.1016/S0376-8716(03)00058-9] [PMID: 12738349]
[6]
Kacinko, S.L.; Jones, H.E.; Johnson, R.E.; Choo, R.E.; Concheiro-Guisan, M.; Huestis, M.A. Urinary excretion of buprenorphine, norbuprenorphine, buprenorphine-glucuronide, and norbuprenorphine-glucuronide in pregnant women receiving buprenorphine maintenance treatment. Clin. Chem., 2009, 55(6), 1177-1187.
[http://dx.doi.org/10.1373/clinchem.2008.113712] [PMID: 19325013]
[http://dx.doi.org/10.1373/clinchem.2008.113712] [PMID: 19325013]
[7]
Concheiro, M.; Shakleya, D.M.; Huestis, M.A. Simultaneous quantification of buprenorphine, norbuprenorphine, buprenorphine-glucuronide and norbuprenorphine-glucuronide in human umbilical cord by liquid chromatography tandem mass spectrometry. Forensic Sci. Int., 2009, 188(1-3), 144-151.
[http://dx.doi.org/10.1016/j.forsciint.2009.04.005] [PMID: 19406593]
[http://dx.doi.org/10.1016/j.forsciint.2009.04.005] [PMID: 19406593]
[8]
Peters, F.T.; Remane, D. Aspects of matrix effects in applications of liquid chromatography-mass spectrometry to forensic and clinical toxicology--a review. Anal. Bioanal. Chem., 2012, 403(8), 2155-2172.
[http://dx.doi.org/10.1007/s00216-012-6035-2] [PMID: 22549818]
[http://dx.doi.org/10.1007/s00216-012-6035-2] [PMID: 22549818]
[9]
Robin, T.; Barnes, A.; Dulaurent, S. Fully automated sample preparation procedure to measure drugs of abuse in plasma by liquid chromatography tandem mass spectrometry. Anal. Bioanal. Chem., 2018, 410(20), 5071-5083.
[http://dx.doi.org/10.1007/s00216-018-1159-7] [PMID: 29947899]
[http://dx.doi.org/10.1007/s00216-018-1159-7] [PMID: 29947899]
[10]
Langman, L.J.; Snozek, C.L.H. LC-MS in Drug Analysis. Analysis of benzodiazepines for drug-facilitated assaults and abuse settings (urine); Humana Press, 2019, pp. 23-39.
[11]
Sorribes-Soriano, A.; Valencia, A.; Esteve-Turrillas, F.A.; Armenta, S.; Herrero-Martínez, J.M. Development of pipette tip-based poly(methacrylic acid-co-ethylene glycol dimethacrylate) monolith for the extraction of drugs of abuse from oral fluid samples. Talanta, 2019, 205, 120158.
[http://dx.doi.org/10.1016/j.talanta.2019.120158] [PMID: 31450423]
[http://dx.doi.org/10.1016/j.talanta.2019.120158] [PMID: 31450423]
[12]
Verstraete, A.G. Detection times of drugs of abuse in blood, urine, and oral fluid. Ther. Drug Monit., 2004, 26(2), 200-205.
[http://dx.doi.org/10.1097/00007691-200404000-00020] [PMID: 15228165]
[http://dx.doi.org/10.1097/00007691-200404000-00020] [PMID: 15228165]
[13]
Langman, L.J.; Snozek, C.L.H. LC-MS in Drug Analysis. Measurement of buprenorphine and norbuprenorphine in urine; Humana Press, 2019, pp. 51-59.
[14]
Lin, H.R.; Chen, C.L.; Huang, C.L.; Chen, S.T.; Lua, A.C. Simultaneous determination of opiates, methadone, buprenorphine and metabolites in human urine by superficially porous liquid chromatography tandem mass spectrometry. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci., 2013, 925, 10-15.
[http://dx.doi.org/10.1016/j.jchromb.2013.02.020] [PMID: 23507455]
[http://dx.doi.org/10.1016/j.jchromb.2013.02.020] [PMID: 23507455]
[15]
Elsohly, M.A.; Gul, W.; Feng, S.; Murphy, T.P. Hydrolysis of conjugated metabolites of buprenorphine II. The quantitative enzymatic hydrolysis of norbuprenorphine-3-β-D-glucuronide in human urine. J. Anal. Toxicol., 2005, 29(6), 570-573.
[http://dx.doi.org/10.1093/jat/29.6.570] [PMID: 16168181]
[http://dx.doi.org/10.1093/jat/29.6.570] [PMID: 16168181]
[16]
Favretto, D.; Frison, G.; Vogliardi, S.; Ferrara, S.D. Potentials of ion trap collisional spectrometry for liquid chromatography/electrospray ionization tandem mass spectrometry determination of buprenorphine and nor-buprenorphine in urine, blood and hair samples. Rapid Commun. Mass Spectrom., 2006, 20(8), 1257-1265.
[http://dx.doi.org/10.1002/rcm.2444] [PMID: 16550495]
[http://dx.doi.org/10.1002/rcm.2444] [PMID: 16550495]
[17]
Kronstrand, R.; Seldén, T.G.; Josefsson, M. Analysis of buprenorphine, norbuprenorphine, and their glucuronides in urine by liquid chromatography-mass spectrometry. J. Anal. Toxicol., 2003, 27(7), 464-470.
[http://dx.doi.org/10.1093/jat/27.7.464] [PMID: 14607001]
[http://dx.doi.org/10.1093/jat/27.7.464] [PMID: 14607001]
[18]
Liu, Y.; Li, X.; Xu, A.; Nasser, A.F.; Heidbreder, C. Simultaneous determination of buprenorphine, norbuprenorphine and naloxone in human plasma by liquid chromatography/tandem mass spectrometry. J. Pharm. Biomed. Anal., 2016, 120, 142-152.
[http://dx.doi.org/10.1016/j.jpba.2015.12.008] [PMID: 26730511]
[http://dx.doi.org/10.1016/j.jpba.2015.12.008] [PMID: 26730511]
[19]
Fisichella, M.; Odoardi, S.; Strano-Rossi, S. High-throughput dispersive liquid/liquid microextraction (DLLME) method for the rapid determination of drugs of abuse, benzodiazepines and other psychotropic medications in blood samples by liquid chromatography–tandem mass spectrometry (LC-MS/MS) and application to forensic cases. Microchem. J., 2015, 123, 33-41.
[http://dx.doi.org/10.1016/j.microc.2015.05.009]
[http://dx.doi.org/10.1016/j.microc.2015.05.009]
[20]
European Medicines Agency (EMA)/Committee for Medicinal Products for Human Use (CHMP) Guideline on Bioanalytical Method Validation, EMA/CHMP, London, United Kingdom 2011.
[21]
Paixão, T.R.L.C.; Coltro, W.K.T.; Salles, M.O. Forensic analytical methods.Forensic sampling and sample preparation; Royal Society Chem, 2019, pp. 7-35.
[22]
Cui, X.; Ni, C.; Liang, C. Screening and quantitation of forty-six drugs of abuse and toxic compounds in human whole blood by capillary electrophoresis: Application to forensic cases. Microchem. J., 2019, 144, 403-410.
[http://dx.doi.org/10.1016/j.microc.2018.09.031]
[http://dx.doi.org/10.1016/j.microc.2018.09.031]
[23]
Del Balzo, G.; Gottardo, R.; Mengozzi, S. “Positive” urine testing for Cannabis is associated with increased risk of traffic crashes. J. Pharm. Biomed. Anal., 2018, 151, 71-74.
[http://dx.doi.org/10.1016/j.jpba.2017.12.059] [PMID: 29310049]
[http://dx.doi.org/10.1016/j.jpba.2017.12.059] [PMID: 29310049]
Article Metrics
7
1